Nature Awards is currently accepting applications for its MDx Impact Grants 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About Nature Awards - MDx Impact Grants
The MDx Impact Grants focus on leveraging PCR technology to improve diagnostics for Alzheimer’s Disease. The aim is to enhance patient outcomes by developing tests that address unmet clinical needs. Researchers are invited to propose projects utilizing Seegene’s high-multiplex PCR platform to detect and characterize molecular markers associated with Alzheimer’s Disease, including disease staging and progression assessment.
Benefits of Nature Awards - MDx Impact Grants
- Financial Support: Up to 600,000 USD per clinical study
- Technology Access: Use of Seegene’s syndromic PCR technology
- Support: Collaboration with a leading diagnostic company to address clinical needs
Nature Awards - MDx Impact Grants Requirements
- Applicant Type: Research groups with experience in PCR and access to clinical specimens
- Facilities Requirement: Must have access to BSL-2 laboratories
- Regulatory Compliance: Eligible to conduct in vitro diagnostic validation studies per applicable regulations
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
19 November, 2026
Opportunity Application
View details of
Nature Awards - MDx Impact Grants
Apply for Nature Awards - MDx Impact Grants